103 related articles for article (PubMed ID: 16571431)
1. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome.
Newman EA; Mulholland MW
J Am Coll Surg; 2006 Apr; 202(4):612-7. PubMed ID: 16571431
[TBL] [Abstract][Full Text] [Related]
2. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?
Shaw D; Blair V; Framp A; Harawira P; McLeod M; Guilford P; Parry S; Charlton A; Martin I
Gut; 2005 Apr; 54(4):461-8. PubMed ID: 15753528
[TBL] [Abstract][Full Text] [Related]
3. Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
Corso G; Davis JL; Strong VE
J Surg Oncol; 2024 May; 129(6):1082-1088. PubMed ID: 38389278
[TBL] [Abstract][Full Text] [Related]
4. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).
Hallowell N; Lawton J; Badger S; Richardson S; Hardwick RH; Caldas C; Fitzgerald RC
J Genet Couns; 2017 Aug; 26(4):752-762. PubMed ID: 27837291
[TBL] [Abstract][Full Text] [Related]
5. CDH1 gene mutation, a challenging surgical topic: Case report and literature review.
Maalouf H; Saber T; Ghattas S; Meguerian-Bedoyan Z; El Rassi Z
Int J Surg Case Rep; 2024 Mar; 116():109422. PubMed ID: 38394940
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic gastrectomy].
Côme P; Rochefort P; De Crignis L; Dupré A
Bull Cancer; 2024 May; ():. PubMed ID: 38755036
[TBL] [Abstract][Full Text] [Related]
7. Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic
Roberts G; Hardwick R; Fitzgerald RC
Transl Gastroenterol Hepatol; 2017; 2():21. PubMed ID: 28447056
[No Abstract] [Full Text] [Related]
8. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
[TBL] [Abstract][Full Text] [Related]
9. [Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer].
Pantelis D; Lingohr P; Hueneburg R; Spier I; Vilz T; Lau JF; Nattermann J; Aretz S; Strassburg CP; Kalff JC
Zentralbl Chir; 2020 Feb; 145(1):41-47. PubMed ID: 30068014
[TBL] [Abstract][Full Text] [Related]
10. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.
Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG
Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
[TBL] [Abstract][Full Text] [Related]
12. The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study.
Worster E; Liu X; Richardson S; Hardwick RH; Dwerryhouse S; Caldas C; Fitzgerald RC
Ann Surg; 2014 Jul; 260(1):87-93. PubMed ID: 24424140
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family.
Hackenson D; Edelman DA; McGuire T; Weaver DW; Webber JD
JSLS; 2010; 14(3):348-52. PubMed ID: 21333186
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
16. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
17. Pioneering use of genetic analysis for
Mokhtari-Esbuie F; Szeglin B; Ravari MR; Duncan M; Harmon JW
eGastroenterology; 2023 Sep; 1(2):. PubMed ID: 38188186
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary diffuse gastric cancer].
Knipper K; Fuchs HF; Alakus H; Bruns CJ; Schmidt T
Chirurgie (Heidelb); 2023 May; 94(5):400-405. PubMed ID: 36700973
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic Versus Open Total Gastrectomy for Advanced Gastric Cancer: A Multicenter, Propensity Score-Matched Cohort Study in China.
Feng X; Chen X; Ye Z; Xiong W; Yao X; Wang W; Wang J; Chen L; Li Y
Front Oncol; 2021; 11():780398. PubMed ID: 34966682
[TBL] [Abstract][Full Text] [Related]
20. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.
Shenoy S
Cancer Manag Res; 2019; 11():10477-10486. PubMed ID: 31853199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
